Nightstar Therapeutics plc (NITE) – Management Comments
-
Biogen (BIIB) to Acquire Nightstar Therapeutics (NITE) for $25.50/Sh in Deal Valued at Approx. $800M
-
Nightstar Therapeutics plc (NITE) Tops Q3 EPS by 13c
-
-
-
-
Back to NITE Stock Lookup